Abnormalities in central nervous system development in osteogenesis imperfecta type II

Pediatric and Developmental Pathology

Volumn 2, Issue 2, 1999, Pages 124-130

  Emery, Shawn Clark ^a   Karpinski, Nancy C ^a   Hansen, Lawrence ^a,b   Masliah, Eliezer ^a,b  

^a UCSD MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Collagen type I; Neurogenesis; Neuropathology; Osteogenesis imperfecta type II

Indexed keywords

ADULT; ARTICLE; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CELL MATURATION; CLINICAL ARTICLE; FETUS; GENE MUTATION; HUMAN; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL;

ADULT; CENTRAL NERVOUS SYSTEM; COLLAGEN; DEMOGRAPHY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MUTATION; OSTEOGENESIS IMPERFECTA; RETROSPECTIVE STUDIES;

EID: 0032996223     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249900100     Document Type: Article

References (28)

1. Marion MJ, Gannon FH, Fallon MD, Mennuti MT, Lodato RF, Kaplan FS. Skeletal dysplasia in perinatal lethal osteogenesis imperfecta: a complex disorder of endochondral and intramembranous ossification. Clin Orthop 1993;293: 327-337.
2. Risling M, Fried K, Linda H, Carlstedt T, Cullheim S. Regrowth of motor axons following spinal cord lesions: distribution of laminin and collagen in the CNS scar tissue. Brain Res Bull 1993;30:405-414.
3. Smith R. Osteogenesis imperfecta: from phenotype to genotype and back again. Int J Exp Pathol 1994;75:233-241.
4. Keeling JW. Fetal and Neonatal Pathology, 2nd ed. New York: Springer-Verlag, 1993;620-650.
5. Prockcop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995;64:403-434.
6. Sillence DO. Osteogenesis imperfecta nosology and genetics. Ann NY Acad Sci 1988;543:1-15.
7. Cole WG, Dalgleish R. Perinatal lethal osteogenesis imperfecta. J Med Genet 1995;32:284-289.
8. Charnas LR, Marini JC. Communicating hydrocephalus, basilar invagination, and other neurologic features in osteogenesis imperfecta. Neurology 1993;43:2603-2608.
9. Verkh Z, Russell M, Miller CA. Osteogenesis imperfecta type II: microvascular changes in the CNS. Clin Neuropathol 1995;14:154-158.
10. Duband J, Delannet M, Monier F, Garret S, Desban N. Modulations of cellular interactions during development of the neural crest: role of growth factors and adhesion molecules. Curr Top Microbiol Immunol 1996;212:207-227.
11. Dupree JL, Bigbee JW. Retardation of neuritic outgrowth and cytoskeletal changes accompany acetylcholinesterase inhibitor treatment in cultured rat dorsal root ganglion neurons. J Neurosci Res 1994;39:567-575.
12. Bolin LM, Shooter EM. Characterization of Schwann cell neunte promoting activity that directs motoneuron axon outgrowth. J Neurosci Res 1994;37:23-35.
13. Tremble P, Chicquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5:439-453.
14. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329.
15. Potter EL, Craig JM. Pathology of the Fetus and the Infant. New York: Year Book Medical Publishers, 1975.
16. Garcia-Abreu J, Cavalcante LA, Silva LG, Moura N. The extracellular matrix of the midline and non-midline mid-brain glia: correlations with neunte growth-supporting abilities. Braz J Med Biol Res 1996;29:1179-1187.
17. McAllion SJ, Paterson CR. Causes of death in osteogenesis imperfecta. J Clin Pathol 1996;49:627-630.
18. Knisely AS, Frates RE, Ambler MW, Singer DB. Hydrocephalus of intrauterine onset in perinatally lethal osteogenesis imperfecta: clinical, sonographic, and pathologic correlations. Pediatr Pathol 1988;8:367-376.
19. Choi BH. Role of the basement membrane in neurogenesis and repair of injury in the central nervous system. Microsc Res Tech 1994;28:193-203.
20. Monier-Gavelle F, Duband JL. Cross talk between adhesion molecules: control of N-cadherin activity by intracellular signals elicited by betal and beta3 integrins in migrating neural crest cells. J Cell Biol 1997;137:1663-1681.
21. Schievink WI, Michels W, Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders - a review. Stroke 1994;25:889-903.
22. Mahesparan R, Tysnes BB, Edvardsen K, et al. Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol Appl Neurobiol 1997;23:102-112.
23. Meyer MB, Bastholm L, Nielsen MH, et al. Localization of NCAM on NCAM-B expressing cells in inhibited migration in collagen. APMIS 1995;103:197-208.
24. Doucette R. Immunohistochemical localization of laminin, fibronectin, and collagen type IV in the nerve fiber layer of the olfactory bulb. Int J Dev Neurosci 1996;14:945-959.
25. Bonaventure J, Rousseau F, Legeai-Mallet L, LeMerrer M, Munnich A, Maroteaux P. Common mutations in the fibroblast growth factor receptor 3 (FGFR-3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet 1996;63:148-154.
26. Knisely AS, Ambler MW. Temporal lobe abnormalities in thanatophoric dysplasia. Pediatr Neurosci 1988;14:169-176.
27. Jones KL. Smith's Recognizable Patterns of Human Malformation, 5th ed. Philadelphia: W.B. Saunders, 1997;344-345.
28. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, Stevanoviac M, Weissenbach J, Mansour S, Young ID, Goodfellow PN. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;6506:525-530.